Vitae Pharmaceuticals, Inc
SEC CIK 1157602 · VTAE · last insider filing 2016-10-25
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Junius Daniel M | Director | filed 2016 - 2016 |
| Hayden Donald J JR | Director | filed 2014 - 2016 |
| Santini Gino | Director | filed 2014 - 2016 |
| Gunderson Robert V JR | Director | filed 2014 - 2016 |
| Rowland Charles A Jr | Director | filed 2014 - 2016 |
| Leonard John M. | Director | filed 2015 - 2016 |
| Hatfield Jeffrey S. | Director · Chief Executive Officer | filed 2014 - 2016 |
| Bernstein Karen | Director | filed 2015 - 2016 |
| Roberts Bryan E | Director | filed 2014 - 2016 |
| Newhall Charles W III | Director | filed 2014 - 2015 |
| Barrett Peter | Director | filed 2014 - 2014 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Morris Richard Steven | Chief Financial Officer | filed 2014 - 2016 |
| Fratamico Arthur | Chief Business Officer | filed 2014 - 2016 |
| Sable Carole | Chief Medical Officer | filed 2016 - 2016 |
| Applebaum Scott | General Counsel | filed 2016 - 2016 |
| Gregg Richard | Chief Scientific Officer | filed 2014 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.